REZOLUTE, INC. Stock Issued During Period, Shares, Issued for Services
REZOLUTE, INC. (RZLT) reported Stock Issued During Period, Shares, Issued for Services of 8.10 million shares for the 0-month period ending 2018-04-03, per its 10-K filed 2019-09-10.
Discontinued › Shareholders' Equity
us-gaap:StockIssuedDuringPeriodSharesIssuedForServices · last filed 2019-09-10
- 2018-04-03: Stock Issued During Period, Shares, Issued for Services 0 month 8.10M shares; Stock Issued During Period, Shares, Issued for Services 0 month as first filed 1.10M shares.
| Period end | Stock Issued During Period, Shares, Issued for Services 0 month | Stock Issued During Period, Shares, Issued for Services 0 month as first filed |
|---|---|---|
| 2018-04-03 | 8.10M shares 10-K · filed 2019-09-10 | 1.10M shares 10-Q · filed 2018-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Turn Therapeutics Inc. (TTRX) | United States | $0.397B | -25.68 |
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| Vogenx, Inc. (VOGX) | United States | $0.355B | |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| ENANTA PHARMACEUTICALS INC (ENTA) | United States | $0.349B | -6.72 |
| Emergent BioSolutions Inc. (EBS) | United States | $0.347B | -2.43 |